We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.75B
AUM Growth
+$206M
Cap. Flow
+$146M
Cap. Flow %
8.36%
Top 10 Hldgs %
14.9%
Holding
338
New
39
Increased
82
Reduced
149
Closed
38

Top Sells

Rank Stock Value
1
CYBX
CYBERONICS INC
CYBX
+$18.5M
2
FIVE icon
Five Below
FIVE
+$13.2M
3
FARO
Faro Technologies
FARO
+$11.4M
4
AKRX
Akorn Inc
AKRX
+$10.2M
5
MATX icon
Matsons
MATX
+$8.83M

Sector Composition

Rank Sector Weight
1 Industrials 18.82%
2 Healthcare 17.25%
3 Technology 17.24%
4 Consumer Discretionary 13.08%
5 Communication Services 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VB icon
276
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$334K 0.02%
+3,015
New +$342K
LOV
277
DELISTED
Spark Networks SE American Depositary Shares
LOV
$309K 0.02%
80,318
+2,199
+3% +$8.02K
NGVC icon
278
Vitamin Cottage Natural Grocers
NGVC
$654M
$306K 0.02%
15,009
+423
+3% +$9.39K
EWH icon
279
iShares MSCI Hong Kong ETF
EWH
$1.22B
$303K 0.02%
15,300
NRCIB
280
DELISTED
National Research Corp Class B
NRCIB
$293K 0.02%
8,167
+236
+3% +$8.07K
TDG icon
281
TransDigm Group
TDG
$67.7B
$282K 0.02%
+1,234
New +$278K
WDFC icon
282
WD-40
WDFC
$3.15B
$271K 0.02%
2,750
WOOF
283
DELISTED
VCA Inc.
WOOF
$269K 0.02%
+4,882
New +$268K
GWW icon
284
W.W. Grainger
GWW
$60.2B
$267K 0.02%
1,316
-1,650
-56% -$339K
XEL icon
285
Xcel Energy
XEL
$48.8B
$262K 0.02%
7,297
AAP icon
286
Advance Auto Parts
AAP
$3.49B
$258K 0.01%
+1,715
New +$298K
PG icon
287
Procter & Gamble
PG
$339B
$256K 0.01%
3,226
AGRX
288
DELISTED
Agile Therapeutics
AGRX
$253K 0.01%
+13
New +$206K
SBUX icon
289
Starbucks
SBUX
$120B
$252K 0.01%
4,190
LLY icon
290
Eli Lilly
LLY
$1.06T
$248K 0.01%
2,940
ADI icon
291
Analog Devices
ADI
$190B
$242K 0.01%
4,370
-9,400
-68% -$553K
EWS icon
292
iShares MSCI Singapore ETF
EWS
$1.08B
$227K 0.01%
11,019
BMRN icon
293
BioMarin Pharmaceuticals
BMRN
$12.4B
$214K 0.01%
+2,045
New +$214K
VNDA icon
294
Vanda Pharmaceuticals
VNDA
$302M
$210K 0.01%
22,597
+631
+3% +$6.3K
IWC icon
295
iShares Micro-Cap ETF
IWC
$1.52B
$207K 0.01%
+2,875
New +$212K
CSGP icon
296
CoStar Group
CSGP
$12.3B
$205K 0.01%
+9,940
New +$198K
NRC icon
297
NRC Health Common Stock
NRC
$450M
$195K 0.01%
12,173
+345
+3% +$5.24K
EWT icon
298
iShares MSCI Taiwan ETF
EWT
$10.7B
$192K 0.01%
7,530
RRM
299
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
$183K 0.01%
20,251
+590
+3% +$5.17K
DENN
300
DELISTED
Denny's
DENN
$128K 0.01%
12,981
+363
+3% +$3.73K

Similar funds

Rice Hall James & Associates's Q4 2015 Portfolio in Review

As of Q4 2015, Rice Hall James & Associates held 338 positions worth $1.75B, up 13% from $1.54B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates deployed $146M of net new capital in Q4 2015, opening 39 new positions and adding to 82 existing holdings. Its largest new stake was LivaNova: 300,399 shares worth $17.8M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Five Below, an estimated $13.2M trimmed.

  • Rice Hall James & Associates's largest Q4 2015 buy was LivaNova: 300,399 shares worth $17.8M.
  • Rice Hall James & Associates added most to Criteo S.A. Ordinary Shares in Q4 2015, an estimated $10.2M increase.
  • Rice Hall James & Associates's biggest Q4 2015 reduction was Five Below, cutting an estimated $13.2M.
  • Rice Hall James & Associates fully exited CYBERONICS INC in Q4 2015, selling an estimated $18.5M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $1.75B portfolio in Q4 2015.
  • Rice Hall James & Associates opened 39 new positions and closed 38 in Q4 2015.
  • Rice Hall James & Associates's portfolio value rose 13% quarter-over-quarter to $1.75B.

Based on Rice Hall James & Associates's 13F filing for Q4 2015, filed 28 Jan 2016.